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The Korean Society of Nephrology (KSN) launched the ofﬁcial End-Stage Renal Disease
(ESRD) Patient Registry in 1985 and the Internet online registry programwas opened in
2001. The ESRD Registry Committee of KSN has collected data on dialysis therapy in
Korea through the online registry program in the KSN Internet website. The increasing
number of elderly people and diabetic patients in Korea has resulted in a very rapid
increase in the number of ESRD patients. The total number of ESRD patients was 58,860
(hemodialysis [HD], 39,509; peritoneal dialysis [PD], 7309; and functioning kidney
transplant [KT], 12,042). The prevalence of ESRD was 1144.4 patients per million
population (PMP), and the proportion of renal replacement therapy was HD, 67.1%; PD,
12.4%; and KT, 20.5%. The number of new ESRD patients in 2010 was 9335 (HD, 7204;
PD, 867; and KT, 1264; the incidence rate was 181.5 PMP). The primary causes of ESRD
were diabetic nephropathy (45.2%), hypertensive nephrosclerosis (19.2%), and chronic
glomerulonephritis (11.3%). The mean urea reduction ratio was 67.9% in male HD
patients and 73.9% in female HD patients. The mean Kt/V was 1.394 in male patients
and 1.659 in female patients. Five-year survival rates of male and female dialysis
patients were 64.9% and 67.3%, respectively.
& 2012. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The Korean Society of Nephrology (KSN), an association of
scholars and clinicians, has the largest and continuous projectrean Society of Nephrology. P
ses/by-nc-nd/4.0/).
he 31st autumn meeting
vention Center, October
ternal Medicine, Saint
of Korea, 93-6, Ji-dong,
a.
).in which patients are enrolled by all society members; this
project is called the End-Stage Renal Disease (ESRD) Patient
Registry. The ﬁrst Korean nationwide registry of ESRD
patients was reported in 1977 by the late professor Byung
Suk Min, who was assassinated by a North Korean terrorist
while working as a physician for the Korean president in
1983. The KSN launched an ofﬁcial registry program, the
Insan Prof Min Memorial ESRD Patient Registry, in 1985.
The objectives and importance of the patient registry and
statistical evaluation of ESRD can be summarized as follows:
ﬁrst, to estimate the numbers and distributions of targetublished by Elsevier. This is an open access article under the CC BY-NC-
DC Jin et al / Renal replacement therapy in Korea 63therapy patients by a dialysis specialist group (KSN); second,
to know the characteristics of ESRD and dialysis therapy and
its complications or results based on scientiﬁc evidence; and
third, to improve quality of dialysis therapy and provide
information for socioeconomic health administration and40000
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Figure 1. Prevalence and incidence of end stage renal replacement thera
the end of each year (a); point prevalence of renal replacement therapy (b
major causes of end-stage renal disease (d).
CGN, chronic glomerulonephritis; DM, diabetic nephropathy; HD, hemodia
PD, peritoneal dialysis; PMP, patient numbers per million population; RRT,
Table 1. Causes of End-Stage Renal Disease in New Patients
Causes
1992 1994 1996 1998 20
Chronic glomerulonephritis 25.3 25.5 21.6 17.9 14
Not histologically conﬁrmed 19.7 20.4 16.7 13.6 10
Histologically conﬁrmed 5.6 5 4.9 4.3 3
Diabetic nephropathy 19.5 26.1 30.8 38.9 40
Hypertensive nephrosclerosis 15.4 20.8 18.3 17.8 16
Cystic kidney disease 2.1 2.2 1.8 1.7 2
Renal tuberculosis 1.1 1.5 1.2 0.5 0
Pyelo/interstitial nephritis 1.3 1.1 0.7 1 0
Drugs or nephrotoxic agents 1.3 0.1 0.6 0.3 0
Lupus nephritis 0.8 0.7 1 0.5 0
Gouty nephropathy 0.7 0.7 0.6 0.5 0
Hereditary nephropathy 0.3 0.7 0.4 0.2 0
Kidney tumor 0.1 0.1 0.2 0.2 0
Other 4.1 2.7 2.8 3.9 3
Uncertain 28.6 17.8 15.9 16.6 20the future health plan. Recently, because of the increase in
the number of elderly and diabetic patients in the Korean
population, the prevalence of ESRD and number of hemodia-
lysis machines in Korea have increased more rapidly than
those in other developed countries [1,2].1200
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py in Korea. The number of patient with renal replacement therapy at
); patients starting renal replacement therapy in each year (c); three
lysis; HTN, hypertensive nephrosclerosis; KT, kidney transplantation;
renal replacement therapy.
Percent (%)
00 2002 2004 2006 2007 2008 2009 2010n
13.9 12.5 13 11.6 12.1 11.1 11.3
.6 10 8.6 9 8.3 8.2 7.5 7.7
.4 3.9 3.9 3.9 3.3 3.8 3.6 3.6
.7 40.7 43.4 42.3 44.9 41.9 45.4 45.2
.6 16 16.2 16.9 17.2 18.7 18.3 19.2
.2 1.6 1.4 1.7 1.7 1.7 1.8 1.7
.4 0.5 0.3 0.3 0.3 0.2 0.2 0.2
.8 0.6 0.6 0.6 0.5 0.5 0.5 0.4
.3 0.4 0.2 0.3 0.2 0.3 0.3 0.3
.9 0.8 0.6 0.6 0.6 0.6 0.6 0.5
.7 0.4 0.5 0.3 0.3 0.3 0.3 0.4
.1 0.2 0.3 0.3 0.2 0.3 0.2 0.2
.2 0.3 0.3 0.2 0.1 0.2 0.2 0.2
5.6 5.9 6 5.1 5.8 5.2 5.1
.2 19 17.8 17.5 17.2 17.6 16.0 15.3
Kidney Res Clin Pract 31 (2012) 62–7164Methods
The ESRD registry committee of KSN has collected data
on dialysis centers and patients through an online registry
program on the KSN Internet website (http://www.ksn.or.
kr) since 2001. The program also has a graphic evaluation
function of dialysis adequacy (Kt/V, nPCR) and a peritoneal
equilibrium test. For ensuring the security of the patient’s
personal information, the program was accessible only to
designated dialysis staff with a hospital code and pass-
word. Information regarding non-responding dialysis cen-
ters was collected through mail questionnaires.Figure 2. Renal replacement therapy modalities. Proportion of renal replace
hemodialysis centers and hemodialysis machines (b); number of hemodialysis
distribution of hemodialysis patients according to dialysis center classiﬁcationData on dialysis therapy in Korea
Prevalence and incidence of end stage renal disease in Korea
At the end of 2010 in Korea, the overall ESRD patient
number was 58,860, and the number of ESRD patients
under maintenance hemodialysis (HD), peritoneal dialysis
(PD), and with functioning transplanted kidney (KT) were
39,509, 7,309, and 12,042, respectively. The prevalence
per million population (PMP) was 768.1 for HD, 142.1 for
PD, 234 for KT, and 1144.4 for overall ESRD (Fig. 1A and B).
These ESRD prevalence rates are similar to those in mostment modalities. Annual prevalence and incidence in 2010 (a); number of
patients and hemodialysis patients per hemodialysis machine (c); percent
(d); regional distribution of dialysis patients in Korea (e).
DC Jin et al / Renal replacement therapy in Korea 65European countries but are about 50% of those in
the United States and one-third of those in Japan accord-
ing to the international comparison data of the annual
United States renal data report [2–4]. The annual increase
in the rate of prevalence was about 10–12% during
2000–2010.
The number of new patients undergoing renal replacement
therapy in 2010 was 9,335 (181.5 PMP) (Fig. 1C). The number
of new ESRD patients with HD, PD, and KT were 7,204 (140.1
PMP), 867 (16.9 PMP), and 1,264 (24.6 PMP), respectively. The
new PD patient number has been decreasing since 2007,
whereas those of HD and KT have been increasing; this is
consistent with the trend in the United States [2].
The most common causes of ESRD in new patients were
diabetic nephropathy, hypertensive nephrosclerosis, and
chronic glomerulonephritis (45.2%, 19.2%, and 11.3%,0% 20% 40% 60% 80% 100%
30
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Figure 3. Dialysis patient demographics. Gender ratio of hemodialysis an
dialysis patients according to dialysis modalities (b); age distribution of dial
age (c); age distribution of dialysis patients according to underlying disea
Percent of estimated patient number according to year (e); duration of dialy
body mass index in hemodialysis and peritoneal dialysis patients (g); distri
patients. Blood pressure was higher in hemodialysis patients than in periton
pressure in hemodialysis and peritoneal dialysis patients (i).respectively). This is shown in Table 1. Among these three
underlying diseases, the incidence of diabetic nephropathy
increased quite rapidly during 1990–2000 (Fig. 1D). The
proportion of diabetic nephropathy in ESRD patients in
Korea was one of the highest in the world with some Asian
countries and the United States [2].
Renal replacement therapy modalities
Approximately 77.2% of new ESRD patients in 2010
started renal replacement therapy with HD, whereas
approximately 9.3% of patients started PD. The prevalence
rates of HD, PD, and KT were 67.1, 12.4, and 20.5,
respectively (Fig. 2A).
The number of HD centers and HD machines has
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1400
1200
1000
800
600P
at
ie
nt
s
400
200
0
0 20 40 60 80 100
700
600
500
ts 400
en
t
tie
Pa
t
300P
200
100
0
0 20 40 60 80 100
Age
d peritoneal dialysis patients according to year (a); age distribution of
ysis patients according to age. Note that the peak age was shifted to old
ses (d); duration of maintenance hemodialysis and peritoneal dialysis.
sis maintenance in diabetic and non-diabetic patients (f); distribution of
bution of mean blood pressure in hemodialysis and peritoneal dialysis
eal dialysis patients (h); systolic and diastolic blood pressure with pulse
2001
2002
2003
2004
2005
2006
2008
2007
2009
PD 2010
HD 2010
2009
2008
2007
2006
2004
2005
2003
r
2002
2001
1998
1993 r
1985
0% 20% 40% 60% 80% 100%
% of patients
% of patients
HD non DM 2006
2007
2008
2010
2009
2010HD
2009
2008
2007
HD DM 2006
0% 20% 40% 60% 80% 100%
PD DM 2006
2007
2008
2009
2010
2010PD
2009
2008
2007
PD Non DM 2006
0% 20% 40% 60% 80% 100%
HD
2005 2006 2007 2008 2009 2010PD
200
150
100
50
0
10 15 20 25 30 35
BMI
HD
2005 2006 2007 2008 2009 2010PD
1400
1200
1000
800
600P
at
ie
nt
s
P
at
ie
nt
s
400
200
0
60 80 100 120 140 160
Mean Blood Pressure (mmHg)
Pulse
Pressure
(mmHg)
HD
2005 2006 2007 2008 2009 2010PD
180
160 Systolic BP Systolic BP
144.0 ± 19.4 134.2 ± 18.7 
140 mmHg mmHg
120
100 Diastolic BP
±
Diastolic BP
g
m
H
m 80 80.5 11.2 H
81.5 ± 11.2 
H
60
mm g mm g
40
HD pt’s Pulse Pressure PD pt’s Pulse Pressure
63.5 ± 16.4 mmHg 52.6 ± 13.9 mmHg
20 (n=13,299) (n=1,303)
0
Figure 3. (continued)
Kidney Res Clin Pract 31 (2012) 62–71662010, Korea had 637 HD centers and 14,634 HD
machines (Fig. 2B). The ratio of machines per center
was 23.0, and the ratio of patients per machine was 2.7
(Fig. 2C).Approximately one-third of maintenance HD patients
were admitted in university hospitals in the late 1990s,
but currently about 50% of HD patients are treated in
private dialysis clinics (Fig. 2D).
DC Jin et al / Renal replacement therapy in Korea 67Analysis of the distribution of ESRD patients according
to the zones in Korea showed that approximately 50% of
HD patients and more than 50% of PD patients were
located in the capital area (Fig. 2E).Dialysis patient demographics
The sex ratio of men to women was 57.6% vs. 42.4% in
HD therapy and 55.6% vs. 44.2% in PD therapy (Fig. 3A).
The mean age of dialysis patients was 58.0713.7 years.
The age distribution of dialysis patients showed two peaks:
One peak at the age of 50 years and another peak at the age
of 65 years (Fig. 3B), indicating that at least two or more
different disease groups are present among ESRD patients.
The age distribution according to year since 1986 showed
that the peak age has been shifting to older age and the
current peak age is in the 60s (Fig. 3C). The percentage of
dialysis patients aged more than 65 years increased to up
to 35.0% of overall dialysis patients in 2010.
The age distribution according to underlying disease
showed that the peak age of chronic glomerulonephritisHematocrit
(%)
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Figure 4. Characteristics of erythropoietin, hemodialysis, and periton
hemodialysis vs. peritoneal dialysis (a); percent distribution of erythropoie
(b); frequency of hemodialysis per week (c); current use of hemodialysis me
private clinics (d); distribution of the urea reduction ratio in hemodia
hemodialysis patients (f); dialysis adequacy parameters (Kt/V) in diabetic
dialysis types and doses (percentage) (h).was 52.1 years and that of diabetic nephropathy was 61.0
years (Fig. 3D).
About 43% of HD patients and 41% of PD patients had
been undergoing dialysis for more than 5 years; these
percentages had increased from 30% and 14%, respectively,
in 2001 (Fig. 3E).
Approximately 51% of non-diabetic HD patients had
been undergoing dialysis for more than 5 years, whereas
only 29% of diabetic HD patients had been undergoing
dialysis for more than 5 years. Similarly, approximately
42% of non-diabetic PD patients and 28% of diabetic PD
patients had been undergoing dialysis for more than
5 years (Fig. 3F).
The mean body mass index (BMI) was 21.8673.2 kg/m2
in HD patients and 23.5173.6 kg/m2 in PD patients; this
showed a steady increase in both HD and PD groups. In HD
patients, the mean BMI was 22.3573.3 kg/m2 in diabetic
patients and was 21.5473.1 kg/m2 in non-diabetic
patients (Fig. 3G).
The mean blood pressures were similar between HD
patients and PD patients (101.7712.2 mmHg and
99.1712.5 mmHg, respectively), but the pulse pressure2001
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Kidney Res Clin Pract 31 (2012) 62–7168was much higher in HD patients than in PD patients (63.4
vs. 53.0 mmHg). These results are shown in Fig. 3H and I.
Although the blood pressure of dialysis patients is decreas-
ing, the pulse pressure of HD patients is increasing, and this
is associated with the risk of cardiovascular morbidity.Characteristics of erythropoietin, HD, and PD therapies
In 2010, the mean hematocrit was 31.5% in HD patients
and 30.1% in PD patients; this was a relative reversal of the
values from 2001 (Fig. 4A). Although PD patients theoreti-
cally have a lower prevalence of anemia than HD patients,
the recent use of erythropoietin therapy has increased
hematocrit values in HD patients more than PD patients.
This therapeutic results is shown quite clearly in Fig. 4A
and B: 31% of HD patients were injected with 8000 or more
units of erythropoietin per week, whereas only 15% of PD
patients were injected with this level of erythropoietin and
20% of PD patients were not injected with erythropoietin.
The increase of both dialysis patients’ hematocrit values in
2004 and 2005 was due to the increase in the reimburse-
ment level of erythropoietin therapy.Recently, most HD patients (91.3%) received dialysis
three times per week (Fig. 4C). Most HD centers (87%)
used polysulfone dialyzer, whereas approximately 4% of
centers used a reusable dialyzer; hemodiaﬁltration ther-
apy was available in 43% of dialysis centers in Korea
(Fig. 4D).
The urea reduction ratio was 67.9% in male HD patients
and 73.9% in female HD patients (Fig. 4E). This sex
difference of dialysis adequacy resulted from the use of
similar dialysis dose in men and women in spite of body
mass difference between the genders. The overall mean
urea reduction ratio was 70.577.2%; this showed a steady
increase.
The average normalized protein catabolic rates and Kt/V
were 0.97470.29 and 1.50870.37, respectively. Similar
to the urea reduction ratio, both these values were higher
in women than in men (Fig. 4F). Kt/V was higher in non-
diabetic patients than in diabetic patients, presumably
because of the quality of vascular access for dialysis
(Fig. 4G).
The annual quality improvement in HD therapy is
shown in Fig. 4E–G. However, the recent protein cata-
bolic rate showed a slight decrease, presumably because
Table 3. Causes of Death (%) in Dialysis Patients, 1994–2010n
1994–96 1998 2001 2002
Cardiac 27.4 27.4 26.9 27.9
Myocardial infarction 6.4 6.4 7.7 5.5
Cardiac arrest, uremia associated 13.7 13.7 11.2 10.6
Cardiac arrest, other cause 7.2 7.2 8.1 11.8
Vascular 17.2 17.2 22.7 15.7
Cerebrovascular accident 14.3 14.3 15.1 11.6
Pulmonary embolus 0.2 0.2 0.5 0.4
Gastrointestinal hemorrhage 1.7 1.7 2.7 1.9
Gastrointestinal embolism 0.1 0.1 0.1 0.1
Other vascular disease 0.9 0.9 4.3 1.7
Infection 13.5 13.5 17.8 21.6
Pulmonary infection 2.5 2.5 4.5 4.9
Septicemia 6.6 6.6 6.9 9.2
Tuberculosis 0.3 0.3 0.8 0.5
Peritonitis 2.1 2.1 1.1 2.5
Other infection 2 2 4.5 4.5
Liver disease 3.4 3.4 2.6 2.8
Liver failure due to hepatitis B 1.8 1.8 1.6 1.2
Liver failure due to other cause 1.6 1.6 1 1.6
Social 6.2 6.2 6.3 4.7
Patient refused further treatment 2.9 2.9 2.1 1.8
Suicide 2.5 2.5 3.3 1.9
Therapy ceased for other reason 0.8 0.8 0.9 1
Miscellaneous 32 32 23.7 27.4
Cachexia 2.9 2.9 8.1 6.8
Malignant disease 2.1 2.1 4.4 4.8
Accident 1.2 1.2 0.9 0.5
Uncertain 25.8 25.8 10.3 15.3
n Number of patients: 1994–1996¼981, 1998¼911, 2001¼761, 2002¼1,2
2008¼1,563, 2009¼1,727, 2010¼1,802.
Table 2. Comorbidities of Dialysis Patients in 2010n
Hemodialysis Peritoneal
dialysis
Cardiac 17.1 18.8
Coronary artery disease 7.7 7.8
Congestive heart failure 4.1 8.9
Pericardial effusion 1.5 0.8
Arrhythmia 3.8 1.3
Vascular 51.1 46.5
Cerebrovascular accident 5.2 5.5
Hypertension 44.0 37.6
Other vascular disease 2.0 3.4
Infection 6.5 19.1
Pneumonia 1.4 2.9
Tuberculosis 1.1 1.6
Peritonitis 1.0 10.4
Herpes zoster 0.3 0.0
Other infection 2.9 4.2
Liver disease 7.7 3.9
Hepatitis B 4.7 3.1
Hepatitis C 2.6 0.5
Congestive liver 0.0 0.3
Hemochromatosis 0.0 0.0
Other liver diseases 0.4 0.0
Gastrointestinal 8.6 7.8
Gastric ulcer 2.0 3.1
Duodenal ulcer 0.5 1.6
Other gastrointestinal diseases 6.1 3.1
Miscellaneous 8.9 3.9
Malnutrition (Albo2.5 g/dl) 0.6 0.8
Malignancy 1.8 0.5
Hypertensive retinopathy 1.1 1.0
Uremic dermatitis 1.6 0.3
Uremic neuritis 1.6 0.3
Uremic dementia 0.7 0.0
Uremic ascites/pleural effusion 0.5 0.3
Osteodystrophy 0.9 0.8
n Reported patients number: hemodialysis¼4,185; peritoneal dialysis¼
383.
DC Jin et al / Renal replacement therapy in Korea 69of the increase in the proportion of elderly dialysis
patients.
The percent of automated PD patients had increased to
22% in 2010, but the overall PD dose (dialysate amount)
did not increase (Fig. 4H).Morbidities, causes of death, and survival rates of dialysis
patients
The most common complication (51%) in HD patients
was vascular diseases, which included hypertension,
cerebrovascular accident, and other vascular diseases
(Table 2). Furthermore, 46.5% of PD patients had vascular
disease, and the infection complication rate was higher in
PD patients (19.1%) than in HD patients (6.5%).
The causes of death in dialysis patients in descending
order of frequency were cardiac causes, infection, and
vascular disease. The cause of death was unknown or
miscellaneous in one-quarter of dialysis patients (Table 3
and Fig. 5A). Some year-to-year variation was observed
because of limitations in death reports.
The overall 1- and 5-year survival rates of dialysis
patients were 94% and 66%, respectively (Fig. 5B). These
survival rates were higher than those in the United States
and Japan [2,3], but the Korean survival rate was calcu-
lated only from registered dialysis patients from 2001. The
Korean ESRD registry covers only about two-thirds of all
dialysis patients in Korea because registry enrollment is
voluntary.
The 5-year survival rate was higher in HD patients than
in PD patients (67.4% vs. 59.9%, Fig. 5C), and the 5-year
survival rate was higher for non-diabetic patients than for
diabetic patients (75.4% vs. 55.8%, Fig. 5D).2003 2004 2005 2006 2007 2008 2009 2010
31.7 35.5 30.7 33.7 31.7 35.1 29.5 31.1
7.4 8.3 8 9.1 7.5 9.7 8.0 8.3
11.7 13.6 10.4 11.1 10.8 11 8.5 8.7
12.5 13.6 12.4 13.5 13.3 14.4 13 14.2
19.5 17.5 17 16.5 17.8 16 15.9 13.3
14.5 12.8 12.3 11.5 13 12.2 11 8.2
0.1 0.2 0.6 0.7 0.5 0.1 0.2 0.1
3.2 2 1.7 1.8 2.7 1.9 2.3 2.6
0 0.4 0.5 0.5 0.1 0.1 0.5 0.4
1.6 2.1 1.9 2 1.6 1.7 1.9 2.2
20.5 19.5 20.1 18.8 20.2 19.5 21.9 22.6
3.6 3.7 4.5 4.2 4.4 4.4 5.9 7.5
9.7 9.4 9.6 8.9 11.7 9 10.4 10.7
0.2 0.1 0.3 0.1 0.2 0.1 0.3 0.2
2 1.5 1.4 1.1 1.1 2 0.8 1.2
4.9 4.8 4.3 4.5 2.9 4 4.5 2.9
2.8 2.9 2.7 2.6 2.2 1.9 3.1 2.7
1.8 2.1 1.5 1.4 1.3 1 2.2 1.2
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Figure 5. Morbidities, causes of death, and survival rates of dialysis patients. Comparison of causes of death in hemodialysis vs. peritoneal
dialysis patients in 2001–2010 (a); overall survival of registered dialysis patient since 2001 (male: n¼22,257; female: n¼16,520) (b); HD and
PD dialysis patient survival since 2001 (HD: n¼31,354, PD: n¼7423) (c); overall diabetic and non-diabetic dialysis patient survival since 2001
(Non-DM: n¼18,786; DM: n¼19,991) (d).
DM, diabetic nephropathy; HD, hemodialysis; PD, peritoneal dialysis.
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Figure 6. Annual number of kidney transplantations (KT) in Korea (including data from the Korean Network for Organ Sharing).
*Surviving KT waiting patient number at the end of each year.
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In 2010, kidney transplantation was performed in 1,264
cases, which included 495 deceased donors (Fig. 6). The
kidney transplantation rate was 27 cases per 1000 dialysis
patients, which was below the world average [2]. How-
ever, the waiting number has been increasing sharply, and
9,622 surviving dialysis patients were enrolled in the
Korean Network of Organ Sharing waiting list at the end
of 2010.Discussion
The increasing proportion of elderly and diabetic
patients in the population has resulted in a rapid increase
in the number of ESRD patients, which reached 1,144 PMP
at the end of 2010. A high proportion of diabetic ESRD
patients (45%) and a decrease in the proportion of PD
patients were recently observed. Among ESRD patients, the
HD proportion has increased to 77.2% and the PD propor-
tion has decreased to 9.3%. The adequacies of dialysis and
anemia therapy have been steadily improving in Korea.Conﬂict of interest
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